Eyre Brik V 4
4 · BAXTER INTERNATIONAL INC · Filed May 23, 2018
Insider Transaction Report
Form 4
Eyre Brik V
CVP, Hospital Products
Transactions
- Exercise/Conversion
Common Stock, $1 par value
2018-05-22$37.38/sh+25,000$934,500→ 90,115 total - Sale
Common Stock, $1 par value
2018-05-22$71.96/sh−25,000$1,799,000→ 65,115 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-05-22−15,828→ 0 totalExercise: $37.38From: 2017-03-03Exp: 2025-03-03→ Common Stock, $1 par value (15,828 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2018-05-22−9,172→ 42,243 totalExercise: $37.38From: 2018-03-05Exp: 2025-03-03→ Common Stock, $1 par value (9,172 underlying)
Footnotes (2)
- [F1]Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Eyre with respect to certain vested stock options granted by Baxter International Inc. ("BII") to Mr. Eyre.
- [F2]Price reflects weighted average sales price. Range of prices for transactions are $71.65 through $72.37. Full information regarding the number of shares sold at each separate price will be provided by BII upon request.